Jagsonpal Pharmaceuticals Ltd

Desk›Healthcare› Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd

BSE 507789 · NSE JAGSNPHARM · ISIN INE048B01035 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹238.20

-1.77%

BSE close, 28 August 2026

Market cap

₹1,570.44 cr

6.6 cr shares · Micro cap

Free float

₹414.38 cr

as published

P/E · P/B

34.5× · 7.96×

EPS ₹6.91 · BV ₹29.92

FY25-26 rev / PAT

287.23 / 43.08

₹ cr, as filed

Filings, window

9 selected · 32%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-10.0%
Against 52-week low	+53.8%
Day change	-1.77%
Size band	Micro cap
Index membership	None

Valuation as published by BSE

Earnings per share	₹6.91
Price / earnings	34.47×
Price / book	7.96×
Book value — derived, price ÷ P/B	₹29.92
Return on equity	23.07%
Operating margin	24.41%
Net margin	16.04%

Consistency check

P/B ÷ P/E, which must equal ROE: 23.09%
ROE as published: 23.07%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	82.23	13.19	2.00	24.41%	16.04%
Mar-26 · Q	64.20	8.76	1.25	22.32%	13.65%
FY25-26	287.23	43.08	6.40	23.67%	15.00%

Quarter on quarter

Revenue, quarter on quarter: +28.1%
Net profit, quarter on quarter: +50.6%
Operating margin, quarter on quarter: +209 bps

Disclosure profile 28 filings in the window

Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Acquisition	2
Press Release	2
Board Outcome	1
Change in Management	1
Concall Transcript	1
Investor Presentation	1
Results	1
Selected sub-total	9
Procedural
Newspaper Publication	4
AGM / EGM	3
ESOP Allotment	3
Analyst / Investor Meet	2
Annual Report	1
BRSR	1
Board Meeting	1
Compliance Certificate	1
General	1
Record Date	1
Trading Window	1
Procedural sub-total	19
Total	28

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

28 filings · 9 selected · busiest 2026-07-29

Filing rhythm · the twelve most recent

2026-08-272026-10-09

SelectedProcedural

Filings

28 in the window · 12 earlier on record

9 October 2026 · 15:57 IST

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
1 October 2026 · 16:57 IST

Acquisition

Updates on Acquisition

Subsequent to fulfilment of the Conditions Precedent under the BTA the transactions has been consummated with effect from today i.e. October 01, 2026.

Company Update / Acquisition View filing →
30 September 2026 · 16:13 IST

Newspaper Publication

Newspaper Publication

Newspaper Advertisement regarding transfer of Shares to IEPF and Notice of loss of share Certificate

Company Update / Newspaper Publication View filing →
30 September 2026 · 16:08 IST

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 101825 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022

Company Update / Allotment of ESOP / ESPS View filing →
25 September 2026 · 16:39 IST

Trading Window

Closure of Trading Window

Closure of Trading window for the quarter and six months ended September 30, 2026.

Insider Trading / SAST / Closure of Trading Window View filing →
23 September 2026 · 18:02 IST

Press Release

Press Release / Media Release

Press Release on Acquisition of Wellness Portfolio of Group pharmaceuticals Limited

Company Update / Press Release / Media Release View filing →
23 September 2026 · 17:52 IST

Acquisition

Acquisition

Acquisition of the Wellness Portfolio of Group Pharmaceuticals Limited.

Company Update / Acquisition View filing →
21 September 2026 · 17:05 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Voting Result and scrutinizer Report of 47th Annual General Meeting.

AGM/EGM / AGM View filing →
18 September 2026 · 17:11 IST

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

Summary of Proceedings of 47th Annual General Meeting.

AGM/EGM / AGM View filing →
28 August 2026 · 12:05 IST

Newspaper Publication

Newspaper Publication

Newspaper Publication for dispatch of Notice of 47th Annual General Meeting, Annual Report 2025-26 and e-voting

Company Update / Newspaper Publication View filing →
27 August 2026 · 20:18 IST

AGM / EGM

Notice Of 47Th Annual General Meeting And Annual Report For The FY 2025-26

Notice of 47th of Annual General Meeting and Annual Report for F.Y. 2025-26

AGM/EGM / AGM View filing →
27 August 2026 · 20:06 IST

BRSR

Business Responsibility and Sustainability Reporting (BRSR)

BRSR for the Financial year ended March 31, 2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
27 August 2026 · 19:51 IST

Annual Report

Reg. 34 (1) Annual Report.

Annual report for Financial Year 2025-26

Others / Reg. 34 (1) Annual Report View filing →
27 August 2026 · 17:39 IST

General

Announcement Under Regulation 30-SEBI (LODR) Regulations, 2015

Letter providing a web link of annual report 2025-26 to members.

Company Update / General View filing →
24 August 2026 · 11:53 IST

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022

Company Update / Allotment of ESOP / ESPS View filing →
12 August 2026 · 16:58 IST

Newspaper Publication

Newspaper Publication

Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18, 2026

Company Update / Newspaper Publication View filing →
4 August 2026 · 16:19 IST

Concall Transcript

Earnings Call Transcript

Earning Call Transcript for meeting held on July 30, 2026

Company Update / Earnings Call Transcript View filing →
30 July 2026 · 17:30 IST

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY27 Earnings Conference Call on July 30, 2026 at 2:30 P.M.

Company Update / Analyst / Investor Meet View filing →
30 July 2026 · 17:20 IST

Newspaper Publication

Newspaper Publication

Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
29 July 2026 · 18:45 IST

Change in Management

Change in Management

Change in Senior Management personnel of the Company

Company Update / Change in Management View filing →
29 July 2026 · 18:36 IST

Record Date

Corporate Action- Record Date: September 04, 2026

Corporate Action- Record Date for dividend Purpose: September 04, 2026

Corp. Action / Record Date View filing →
29 July 2026 · 18:32 IST

ESOP Allotment

Allotment of ESOP / ESPS

Intimation for grant of Employee Stock Options

Company Update / Allotment of ESOP / ESPS View filing →
29 July 2026 · 18:23 IST

Press Release

Press Release / Media Release

Press Release for Unaudited Financial results for quarter ended June 30, 2026

Company Update / Press Release / Media Release View filing →
29 July 2026 · 18:20 IST

Investor Presentation

Investor Presentation

Press Release for Unaudited Financial Results for quarter ended June 30, 2026

Company Update / Investor Presentation View filing →
29 July 2026 · 17:19 IST

Results

Unaudited Results For The Quarter Ended June 30, 2026

Unaudited results along with its Limited Review Report for the quarter ended June 30, 2026

Result / Financial Results View filing →
29 July 2026 · 17:01 IST

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On July 29, 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30, 2026

Outcome of Board Meeting held on July 29, 2026 along with Unaudited (Standalone) Financial Results for the quarter June 30, 2026

Board Meeting / Outcome of Board Meeting View filing →
22 July 2026 · 16:22 IST

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....

Company Update / Analyst / Investor Meet View filing →
22 July 2026 · 16:18 IST

Board Meeting

Board Meeting Intimation for Prior Intimation Of Board Meeting

Jagsonpal Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the unaudited Financial ....

Board Meeting / Board Meeting View filing →

RSS feed for Jagsonpal Pharmaceuticals Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window